Applied BioSciences Corp. (APPB) financial statements (2022 and earlier)

Company profile

Business Address 9701 WILSHIRE BLVD.
BEVERLY HILLS, CA 90212
State of Incorp.
Fiscal Year End March 31
SIC 204 - Grain Mill Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
6/30/2018
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2173384724273
Cash and cash equivalents2173384724273
Receivables766670163181114
Inventory, net of allowances, customer advances and progress billings10210611579705254
Inventory10210611579705254
Prepaid expense  1665475498
Other undisclosed current assets1517     
Total current assets:214262240354376124169
Noncurrent Assets
Operating lease, right-of-use asset351   
Property, plant and equipment331 412452444
Long-term investments and receivables571898898898873873627
Long-term investments571898898898873873627
Intangible assets, net (including goodwill)1,9411,9411,9411,941   
Goodwill1,9411,9411,9411,941   
Other noncurrent assets1010306666
Other undisclosed noncurrent assets 373  550  
Total noncurrent assets:3,2043,2223,2823,2971,432883637
TOTAL ASSETS:3,4183,4843,5213,6511,8091,007807
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,132636245279334035
Accounts payable660325245279334035
Accrued liabilities472311     
Debt364275200  793
Other undisclosed current liabilities52341123096150238121
Total current liabilities:2,0191,323675374183356158
Noncurrent Liabilities
Long-term debt and lease obligation512250     
Long-term debt, excluding current maturities250250     
Operating lease, liability262   
Other undisclosed noncurrent liabilities(250)731    (15)
Total noncurrent liabilities:262981    (15)
Total liabilities:2,2802,303675374183356143
Stockholders' equity
Stockholders' equity attributable to parent, including:1,1382,1611,7882,1351,644669648
Common stock0000000
Additional paid in capital7,3227,0907,0206,8924,9613,5393,414
Accumulated deficit(8,086)(6,733)(5,955)(5,531)(5,300)(3,408)(3,297)
Other undisclosed stockholders' equity attributable to parent1,9021,8057247741,982538532
Stockholders' equity attributable to noncontrolling interest9089811,0581,142(18)(19) 
Other undisclosed stockholders' equity(1,817)(1,961)    15
Total stockholders' equity:2291,1812,8473,2771,625650664
Other undisclosed liabilities and equity908      
TOTAL LIABILITIES AND EQUITY:3,4183,4843,5213,6511,8091,007807

Income statement (P&L) ($ in thousands)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
6/30/2018
Q1
Revenues1702442112354134910
Revenue, net10
Cost of revenue(51)(98)(100)(82)(380)(42)(18)
Gross profit:118146112153347(7)
Operating expenses(1,088)(967)(593)(562)(1,418)(300)(551)
Operating loss:(970)(821)(482)(409)(1,385)(293)(559)
Nonoperating income (expense)(456)6651137(507)179 
Debt instrument, convertible, beneficial conversion feature 10077    
Other nonoperating income (expense)(456)(34)(26)137(507)179 
Interest and debt expense893926(74)(507)(66)(2)
Loss before gain (loss) on sale of properties:(1,337)(717)(404)(346)(2,398)(180)(561)
Other undisclosed net income (loss)(89)(139)(20)11450670165
Net loss:(1,426)(855)(424)(232)(1,892)(110)(396)
Net income (loss) attributable to noncontrolling interest(72)(77)(84)40(0)36
Other undisclosed net income (loss) attributable to parent7277 (81)0(7)(13)
Net loss available to common stockholders, diluted:(1,426)(855)(508)(272)(1,892)(114)(402)

Comprehensive Income ($ in thousands)

12/31/2019
Q3
9/30/2019
Q2
6/30/2019
Q1
3/31/2019
Q4
12/31/2018
Q3
9/30/2018
Q2
6/30/2018
Q1
Net loss:(1,426)(855)(424)(232)(1,892)(110)(396)
Comprehensive loss:(1,426)(855)(424)(232)(1,892)(110)(396)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(72)(77)(84)40(0)36
Comprehensive loss, net of tax, attributable to parent:(1,498)(933)(508)(191)(1,892)(107)(389)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: